Arcutis Biotherapeutics: +200% On ZORYVE Approval, But When Is The Next Leg Up?
Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.
Cathie Wood’s ARK Investment bought 28.5K shares of Amazon.com today
EST Cathie Wood’s ARK Investment bought 28.5K shares of Amazon.com (AMZN) today Published first on TheFly – the ultimate ...
Cathie Wood Keeps Betting On Amazon's 'Haul' Play: Ark Loads Up $6M Worth Of Shares
Ark Invest, led by Cathie Wood, traded $6.03 million in 28,509 Amazon shares and sold $10.09 million in 627,775 Rocket Lab ...